MP-1 detects early retinal sensitivity loss in diabetics

Article

The microperimeter (MP-1) is ideal for detecting early retinal sensitivity loss in diabetic patients.

The microperimeter (MP-1) is ideal for detecting early retinal sensitivity loss in diabetic patients, claims a recent investigation in Retina.

Dr M.G. Nittala et al., Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India, completed several ophthalmic examinations on 210 eyes of 160 patients. This included best-corrected visual acuity, slit-lamp examination, indirect ophthalmoscopy and microperimetry. Subjects included healthy participants, diabetics with no retinopathy and patients suffering from different stages of diabetic retinopathy (DR).

Retinal sensitivity significantly decreased in correlation to DR severity. Mean foveal sensitivity was 16.68 ± 2.13 dB in healthy participants, 14.73 ± 3.64 dB in diabetics but no DR and 11.60 ± 5.76 dB in DR patients.

Diabetic patients with no DR experienced a significant loss of retinal sensitivity, compared to healthy subjects. Severe non-proliferative DR presented with a more significant loss of retinal sensitivity in he central 20, compared to those with other stages of DR.

The MP-1 is able to detect retinal sensitivity loss at an earlier stage in diabetic patients without DR. It is also a useful tool for measuring retinal sensitivity in DR patients. The MP-1 features scotomoa mapping, enabling the detection of functional vision in DR patients.

The abstract can be seen here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.